NYSE:CFN - CareFusion Stock Price, News, & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Sign in or create an account to add this stock to your watchlist.
$59.94 0.00 (0.00 %)
(As of 09/25/2018 04:00 PM ET)
Previous Close$59.94
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market Capitalization$12.24 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
CareFusion logoCareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.

Receive CFN News and Ratings via Email

Sign-up to receive the latest news and ratings for CFN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNYSE:CFN
CUSIP14170T10
Phone+1-800-6848880

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins16.18%
Return on Equity12.80%
Return on Assets7.62%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$12.24 billion

CareFusion (NYSE:CFN) Frequently Asked Questions

What is CareFusion's stock symbol?

CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."

How were CareFusion's earnings last quarter?

CareFusion Co. (NYSE:CFN) released its earnings results on Thursday, February, 5th. The healthcare company reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.79 by $0.20. The healthcare company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.01 billion. CareFusion had a return on equity of 12.80% and a net margin of 16.18%. The company's revenue was up 15.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.54 EPS. View CareFusion's Earnings History.

What is CareFusion's stock price today?

One share of CFN stock can currently be purchased for approximately $59.94.

How big of a company is CareFusion?

CareFusion has a market capitalization of $12.24 billion.

What is CareFusion's official website?

The official website for CareFusion is http://www.carefusion.com.

How can I contact CareFusion?

CareFusion's mailing address is 3750 Torrey View Ct, SAN DIEGO, CA 92130-2622, United States. The healthcare company can be reached via phone at +1-800-6848880.


MarketBeat Community Rating for CareFusion (NYSE CFN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  370
MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe CFN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CFN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel